- Home
- ORIO vs TXMD Comparison
ORIO vs TXMD Comparison
Compare ORIO & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIO | TXMD |
|---|---|---|
| Founded | N/A | 2008 |
| Country | Canada | United States |
| Employees | 188 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 24.3M |
| IPO Year | 2014 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ORIO | TXMD |
|---|---|---|
| Price | $1.00 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 80.0K | 20.1K |
| Earning Date | 03-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | $74.52 | N/A |
| Revenue Next Year | $5.07 | N/A |
| P/E Ratio | ★ $4.93 | $102.50 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.61 | $0.99 |
| 52 Week High | $1.40 | $2.95 |
Technical Indicators
Market Signals| Indicator | ORIO | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 39.47 |
| Support Level | $0.98 | $1.93 |
| Resistance Level | $1.13 | $2.16 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 15.55 | 5.58 |
Price Performance
Historical ComparisonAbout ORIO Orion Digital Corp. Common Shares
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.